01 / 03 / 2020 | Birgit Schilling
01 / 03 / 2020 | Birgit Schilling
The length of time we remain in good health is the focus of Birgit Schilling and the team at the Buck Institute for Research on Aging. The team’s mass spectrometry-based proteomics studies use data independent acquisition to look for biomarkers of aging and age-related diseases that can threaten an individual’s health span. The researchers see a future where non-invasive tests enable early intervention and the preservation of health.
Birgit Schilling, PhD
Associate Professor
Buck Institute for Research on Aging
Director of the Mass Spectrometry Center
Buck Institute for Research on Aging